Why the study?
The optimal anticoagulation strategy for obese patients with superficial vein thrombosis remains unclear.
Does obesity increase the risk of VTE recurrence in patients with lower limb superficial vein thrombosis?
Does obesity increase the risk of VTE recurrence in patients with lower limb superficial vein thrombosis?
Obesity does not appear to increase the risk of VTE recurrence or major bleeding in patients with lower limb superficial vein thrombosis treated with standard prophylactic anticoagulation.
No takes yet. Share an insight, caveat, or question.
Supports standard anticoagulation in obese SVT; hypothesis-generating and should not yet change practice.
Ordieres‐Ortega et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: